Idrapril

N/A

Report date: 2022/05/25 17:33:31
NME

Base Information

Drug NameIdrapril
Drug Alias Name伊屈普利LG-32001Idrapril
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGuidotti
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuidotti
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A